Popular Articles From: ADT Reports Fourth Quarter and Full Year 2014 Results to How to Stress-Test a Portfolio's Interest-Rate Sensitivity


The ADT Corporation (NYSE:ADT): FOURTH QUARTER 2014 FINANCIAL HIGHLIGHTS GAAP results: revenue of $883 million, net income of $82 million, diluted EPS of $0.47 Diluted EPS before special items of $0.55 (1) ; up 19.6% over prior year period Recurring revenue of $819 million, up 5.4% or 5.8% in constant currency (1)(2) EBITDA before special items of $458 million (1) , up $27 million or 6.3% EBITDA margin before special items of 51.9% (1) , up 100 basis points from prior year Operating cash flow of $354 million and steady-state free cash flow of $966 million (1) , up 3% from prior year FOURTH QUARTER 2014 BUSINESS HIGHLIGHTS The ADT Corporation (NYSE:ADT) today
Sign-up for ADT Reports Fourth Quarter and Full Year 2014 Results investment picks
ROSELAND, N.J., Nov.
Sign-up for ADP to Present at the NASDAQ OMX 31st Investor Program investment picks
ROSELAND, N.J., Sept.
Sign-up for ADP Announces Record Date for Spin-off of CDK Global Shares investment picks
Archer Daniels Midland Company (NYSE: ADM) will webcast its investor day on Wednesday, Dec.
Sign-up for ADM to Host Investor Day on Dec. 3 investment picks
Activision Blizzard, Inc. (Nasdaq: ATVI) today announced better-than-expected financial results for the third quarter of 2014.
Sign-up for Activision Blizzard Announces Better-Than-Expected Third Quarter 2014 Financial Results investment picks
SAN DIEGO and WORCESTER, Mass., Nov.
Sign-up for Acquisition of World Energy Solutions, Inc. (XWES) by EnerNOC, Inc. (ENOC) May Not Be in Shareholders' Best Interests investment picks
Forty percent of North American consumers have used their smartphones to make a payment at a merchant location, according to an Accenture (NYSE:ACN) survey of 4,000 consumers in the U.S. and Canada, up from 16 percent reported in a similar survey two years ago.
Sign-up for Accenture Survey Shows 40 percent of North American Consumers Have Used Smartphones to Make a Merchant Payment, Up from 16 Percent in 2012 investment picks
Accenture (NYSE:ACN) reported financial results for the fourth quarter and full fiscal year ended Aug.
Sign-up for Accenture Reports Fourth-Quarter and Full-Year Fiscal 2014 Results, With Record Annual Revenues and New Bookings investment picks
Accenture (NYSE:ACN) has been named to the ‘Winner’s Circle’ of HfS Research’s Blueprint Report for Talent Acquisition Service Providers.
Sign-up for Accenture Positioned in ‘Winner’s Circle’ For Talent Acquisition Service Providers According to Report by HfS Research investment picks
Accenture (NYSE:ACN) and SAP SE (NYSE:SAP) today announced a new version of the SAP® Upstream Operations Management application, which enables oil and gas companies to improve the accuracy of production data and identify production-optimization opportunities.
Sign-up for Accenture and SAP Announce New Upstream Operations Management Solution to Simplify Monitoring and Managing Production for Oil and Gas Companies investment picks
Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today announced that it plans to host and webcast a series of online seminars with thought-leading experts in diseases for which sotatercept and luspatercept (ACE-536) are being developed.
Sign-up for Acceleron to Host Educational Webcast Series with Clinical Thought Leaders investment picks
Statistically significant mean placebo-adjusted reduction of triglycerides of 36.4% at 1 gram and 38.6% at 2 gram daily doses of CaPre® Statistically significant reduction of 5.3% in non-HDL-C using 2 grams of CaPre® daily (considered the most accurate risk marker for cardiovascular disease) No increases in LDL-C (bad cholesterol) and slight increases in HDL-C (good cholesterol) Clinically meaningful mean placebo-adjusted reduction in VLDL-C of 10.9% and 13.5% at 1 gram and 2 gram daily doses CaPre®, respectively (VLDL-C is considered a highly significant predictor of cardiovascular disease) Statistically significant dose dependent improvement in Omega-3 Index (a risk factor for coronary heart disease) CaPre® shown to be safe, well tolerated and effective LAVAL, Quebec, Sept.
Sign-up for Acasti Reports Successful CaPre(R) Phase II TRIFECTA Results Proving Statistically Significant Improvements in Triglycerides & Non-HDL-C investment picks
WASHINGTON, Nov.
Sign-up for Abengoa to Continue With Palen Project Development investment picks
- Reports Third-Quarter Adjusted EPS of $0.89, Up 8.5 Percent and Well Above the Previous Guidance Range of $0.77 to $0.79; Reports GAAP EPS of $0.31 - Significantly Raises 2014 Adjusted EPS Guidance Range to $3.25 to $3.27 from $3.06 to $3.16 (GAAP EPS Guidance Range is $1.15 to $1.17); 2014 Guidance Excludes Any Potential HCV Revenue - Delivers Revenue of $5.019 Billion, an Increase of 7.8 Percent Over Third-Quarter 2013 (Up 8.3 Percent On an Operational Basis); Revenue Up 13.5 Percent Operationally Excluding Lipid Sales - Revenue Growth Reflects 17.5 Percent Global Sales Growth from HUMIRA (Up 17.8 Percent on an Operational Basis) and Strong Growth from Other Key Products - Continues to Expect U.S. Approval of HCV Combination in 2014; Announced Novel R&D Collaboration with Calico to Develop Medicines for Age-Related Diseases; Further Strengthened Pipeline with Global Collaboration to Develop and Commercialize Duvelisib, PI3K-Inhibitor for Treatment of Cancer
Sign-up for AbbVie Reports Third-Quarter 2014 Financial Results investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G027138-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/11/24/11G027138/Vericel_logo-939520485648.jpg CAMBRIDGE, MA--(Marketwired - November 24, 2014) - Aastrom Biosciences, Inc. (NASDAQ: ASTM), a leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases and conditions, today announced the change of its corporate name to Vericel Corporation (NASDAQ: VCEL) ("Vericel"), effective immediately.
Sign-up for Aastrom Biosciences Changes Name to Vericel Corporation investment picks
AAC Holdings, Inc. (NYSE: AAC), the parent holding company of American Addiction Centers, Inc., announced details for the release of its results for the third quarter ended September 30, 2014.
Sign-up for AAC Holdings, Inc. Schedules Third Quarter 2014 Earnings Release and Conference Call Dates investment picks
SANTA MONICA, Calif., Nov.
Sign-up for A-Mark Precious Metals to Present at the 2014 LD Micro Conference on December 2 investment picks
Updates full-year 2014 guidance Announces conference call to discuss preliminary results Sets date to discuss final results for third quarter ROCK HILL, S.C., Oct.
Sign-up for 3D Systems Announces Preliminary Third Quarter 2014 Results investment picks
- Opportunity to support substantial number of companies migrate from enterprise systems to cloud computing platforms in China BEIJING , Sept.
Sign-up for 21Vianet And IBM Launch Enterprise Cloud Managed Services In China investment picks
Express Scripts Medicare Choice and Value plans offer America's seniors quality, value in Part D ST.
Sign-up for 2015 Express Scripts Medicare Prescription Drug Plans Earn CMS 4-Star Quality and Performance Rating investment picks
Molina wins seventh consecutive Award; fans have 24 hours to vote for Rawlings Platinum Glove Award™ ST.
Sign-up for 2014 Rawlings Gold Glove Award® Winners Announced investment picks
Life Time – The Healthy Way of Life Company (NYSE: LTM ) and the Palm Beach Marathon and Run Fest announced that Eau Palm Beach Resort & Spa , located on the beach in Manalapan, Fla., is the title sponsor of the 11 th annual Palm Beach Marathon and Run Fest .
Sign-up for 2014 Palm Beach Marathon and Fun Fest Names Eau Palm Beach Resort & Spa as Title Sponsor investment picks
In the news release, DICK'S Sporting Goods Announces Grand Opening Celebration in Easton, MD , issued 27-Oct-2014 by DICK'S Sporting Goods over PR Newswire, we are advised by the company that the first paragraph should read, "DICK'S Sporting Goods (NYSE: DKS) , the largest U.S. based full-line omni-channel sporting goods retailer, will be opening its 14th store in Maryland and 601st store nationwide on Friday, November 7th at Waterside Village at Easton (28564 Marlboro Avenue)." The complete, corrected release follows: DICK'S Sporting Goods Announces Grand Opening Celebration in Easton, MD Special Appearance by Harold Baines PITTSBURGH , Oct.
Sign-up for /C O R R E C T I O N -- DICK'S Sporting Goods/ investment picks
2014/12/05
U.S. REITs have dramatically outperformed the market in 2014. Can the party continue?
Sign-up for A Broad, Low-Cost REIT ETF for a Low-Rate Environment investment picks
2010/08/31
The Combine feature in Morningstar.com's Portfolio Manager tool allows investors to create a streamlined view of their assets to help accomplish specific goals.
Sign-up for Optimize Your Portfolios by 'Combining' Them investment picks
2011/11/15
Following this rule of thumb might serve you well in case interest rates go up.
Sign-up for How to Stress-Test a Portfolio's Interest-Rate Sensitivity investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Popular Articles From: ADT Reports Fourth Quarter and Full Year 2014 Results to How to Stress-Test a Portfolio's Interest-Rate Sensitivity
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent